Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer

TheRcmdrPlugin.survivalPackage: Extending theRCommander Interface to Survival Analysis

(2015) John Fox et al.   Journal of Statistical Software

Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics

(2011) Edoardo Colzani et al.   JOURNAL OF CLINICAL ONCOLOGY

Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study

(2011) J. Cuzick et al.   JNCI-Journal of the National Cancer Institute

The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

(2009) Jonas F. Ludvigsson et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

(2009) Werner Schroth   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer

(2007) Cynthia Owusu et al.   JOURNAL OF CLINICAL ONCOLOGY